Eye & Ent Hospital Of Fudan University

This study tests whether adding the drug tislelizumab to standard chemotherapy and radiation can improve outcomes for people with early-stage NK/T-cell lymphoma, a rare blood cancer. About 60 adults aged 18 to 70 will receive the combination treatment. The goal is to see if this …

This study tests a treatment plan for adults with a rare cancer of the nasal and sinus cavities called rhabdomyosarcoma. The plan includes chemotherapy, radiation, and surgery. The goal is to see how well the tumor shrinks and how long people live without the cancer getting worse…